Skip to main content
OpenTrials
Completed

NCT Number: NCT06705933

Effect of Kinesiotaping on Postpartum Pelvic Girdle Pain

The purpose of this study is to investigate the effect of kinesiotaping on pelvic girdle pain in postpartum women.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pelvic Girdle Pain Musculoskeletal Pain Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Pelvic Pain Signs and Symptoms

Age range

25 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Mariam Sobhy kamal

Cairo, Egypt

About this study

Pregnancy-related pain in the SIJ, lumbosacral region, pubic symphysis, or in any combination of these joints has been coined as pelvic girdle pain (PGP) and has been estimated to affect almost half of all pregnant women. Women with PGP have an increased risk of prenatal anxiety, depressive symptoms and postpartum depression compared with healthy pregnant women.

Kinesio Taping is rehabilitative technique used to facilitate the body's natural healing process while providing support and stability to muscles and joints, without restricting their range of motion. Enhanced rehabilitation is thought to be the effect of stimulated reactivation, proprioceptive training, reduced pain, stimulation of correct movement patterns, and reduction of muscle imbalance.

Kinesio Taping (KT) method has been used to decrease and prevent pain in women suffering from pregnancy related low back pain because of increased muscle relaxation while taping is applied. However, there is lack of knowledge regarding the effect of kinesiotaping on PGP in postpartum women.

Therefore, this study will be conducted to provide physiotherapists with a scientific updated knowledge, concerning the effect of kinesiotaping on pain, level of disability and lumbar flexion and extension ROM in pelvic girdle pain in postpartum women, aiming to improve ADLs of postpartum women. This study may expand the role of physiotherapy in women's health

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All post-partum women < 4 months postnatal having pelvic girdle pain.
  • They will be diagnosed using Faber test, and active straight leg raising test.
  • Their ages will range from 25 to 35 years.
  • Their body mass index (BMI) less than 30 kg/ m².

Exclusion criteria

  • Pregnant women or planning for pregnancy.
  • Cardiovascular diseases.
  • Previous spinal surgery.
  • History of skeletal deformity.
  • Participation at any other exercise training program during this study

Treatment and study plan

Core stability exercise

Other

Lumbo-pelvic stabilizing exercises (posterior pelvic tilt, bilateral hip abduction, bilateral knee raise, bridging, hip shrugging) will be performed three times per week for eight weeks.

Myofascial Release

Other

The participants will receive myofascial release technique for 20 min for 3 times per week for 8 weeks.

Kinesiotaping

Other

The participants will receive Kinesio-Taping over the sacroiliac joint and the hip region. Following a test trial of a small patch for 24 hours, they will be instructed to keep the tape on for 48 hours (it will be replaced after 48 hours) . It will be applied for 8 weeks.

Primary outcomes

  1. Assessment of pain

    Time frame: 8 weeks

    Visual analog scale will be used to assess pain level in each woman in both groups before and after the treatment program. The score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity. The following cut points on the pain VAS have been recommended: no pain (0-4 mm), mild pain (5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm)

Secondary outcomes

  1. Measurement of disability level

    Time frame: 8 weeks

    The Oswestry disability index will be used to assess function disability. It is a questionnaire consisting of 10 questions about the impact of low back pain on daily life. Unlike other outcome measures in which a higher score is typically a better score, a higher score on the ODI indicates a greater level of disability, according to the following scoring criteria:0-4: No disability; 5-14: Mild disability; 15-24: Moderate disability; 25-34: Severe disability; 35-50: Completely disabled

  2. Assessment of lumbar flexion range of motion (ROM)

    Time frame: 8 weeks

    Lumbar flexion ROM will be tested by using the inclinometer. The T12 spinous process and the sacral midpoint as landmarks for inclinometer placement. These original landmarks will be modified to the spinal interspaces between T12-L1 and L5-S1 as an attempt to isolate the lumbar spine, and because it was thought that these landmarks are more easily palpated.

    The trial will begin with the patient in a neutral standing position, with the lumbar spine exposed and feet placed shoulder width apart. The subject will be asked to bend forward as far as possible, keeping their legs straight. This point will be entered as a maximum flexion. Normal lumbar flexion (40-60 degrees).

  3. Assessment of lumbar extension range of motion (ROM)

    Time frame: 8 weeks

    Lumbar extension ROM will be tested by using the inclinometer. The T12 spinous process and the sacral midpoint as landmarks for inclinometer placement. These original landmarks will be modified to the spinal interspaces between T12-L1 and L5-S1 as an attempt to isolate the lumbar spine, and because it was thought that these landmarks are more easily palpated.

    The trial will begin with the patient in a neutral standing position, with the lumbar spine exposed and feet placed shoulder width apart. The patient will then be asked to extend back as far as possible with their hands on their hips. This point will be entered as maximal extension. Normal lumbar extension (20-35 degrees).

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Nov 26, 2024
Registry last updated
Aug 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.